1.Activity of cathepsin D and alpha-1 antitrypsin in patients with hip or knee osteoarthritis
Hong XIA ; Jiaqiang HUANG ; Fuqing MAO ; Ke PENG ; Xu HU
Journal of Central South University(Medical Sciences) 2014;(11):1151-1156
Objective: To assess the activity of cathepsin D (CAT-D) and alpha-1 antitrypsin (AAT) in blood in patients with hip or knee osteoarthritis, and to explore whether these two enzymes could be served as serum biomarkers for cartilage degeneration. Methods: hTe activity of CAT-D and AAT in blood serum of 44 women and 26 men with hip or knee osteoarthritis was determined by the method of ELISA before total joint replacement and on the 10th day atfer the surgery. One hundred healthy volunteers were chosen as the control. All datawere analyzed by using SPSS19.0 sotfware. Results: Compared with the controls, the activity of CAT-D in patients with osteoarthritis was decreased by 25% (P<0.05) and 50% (P<0.05) before and atfer the surgery, respectively. hTe activity of AAT in the osteoarthritis patients before the surgery was not signiifcantly changed compared with the control group (P>0.05), but it was increased by 80% after the surgery than that in the control group (P<0.05). hTere was no signiifcant difference in the activities of 2 enzymes between hip and knee osteoarthritis (P>0.05). hTe gender, hypertension, diabetes and age did not affect the activities of the 2 enzymes (P>0.05). Conclusion: AAT might be a possible inflammatory indicator in the osteoarthritis. CAT-D and AAT enzymes are not affected by gender, age, hypertension and diabetes, etc, and they might be served as potential biomarkers for cartilage degradation.
2.Nutritional Support in the Treatment of Cancer
Jun LV ; Jun ZHANG ; Jiaqiang ZHU ; Ang CAI ; Jia HU
International Journal of Traditional Chinese Medicine 2008;30(5):375-377
Objective To investigate nutritional support in the treatment of cancer in recent years.Methods Seperately diSCUSS on application conditions of enteral nutrition and parenteral nutrition in the treatment of cancer and its advantages and disadvantages.Results Enteral nutrition can improve digestive funcdon,reduce costs and enhance immunity.Parenmral nutrition can supplement insufficiency of enteral niltrition and inhibit tumor growth by selecting the kinds of nuWients to support a normal body function.Conclusion Enteral nutrition combined witll parenteral nutrition iS a suitable means of nutritional support in the treatment ofcancer.
3.Endoscopic management of inverting papilloma in nasal cavity and paranasal sinuses
Jiaqiang SUN ; Jingwu SUN ; Yanming HU ; Qiuping LU ; Yinfeng WANG ; Xianguang LI ; Mingshan WANG ; Zicang JIN ; Feichang YE
Chinese Archives of Otolaryngology-Head and Neck Surgery 2006;0(01):-
OBJECTIVE To evaluate the therapeutic effect of intranasal endoscopic surgery on inverted papilloma of the nasal cavity and paranasal sinuses in stage Ⅰ-Ⅲ. METHODS According to the staging system developed by John H.Krouse,30 cases with inverted papilloma in the nasal cavity and paranasal sinuses in stage Ⅰ-Ⅲ were analyzed retrospectively. All patients were treated by intronasal endscopic surgery and were followed up for 24 months. RESULTS The inverted papilloma was removed completely and no serious complications occurred. One case recurred at 10 month after surgery and pathologically proved to be cancerated. Another 2 case recurred at 6 and 7 month after surgery respectively. Recurred tumors were removed again, no recurrences occurred in the following up period. The recurrence rate was 10 % and canceration rate was 3.3 %. CONCLUSION Endoscopic surgery is an effective method in management of the inverting papilloma in nasal cavity and paranasal sinuses in stage Ⅰ-Ⅲ.
4.The role of prourokinase gene in protecting vein grafts from intimal hyperplasia.
Zhixiong HUANG ; Jiaqiang GUO ; Shengshou HU
Chinese Medical Journal 2003;116(11):1687-1690
OBJECTIVETo study the duration of prourokinase gene expression in vein grafts and the role of the prourokinase gene in protecting vein grafts from neointimal hyperplasia.
METHODSFifty-four Wistar rats were used in this study. In each rat, the jugular vein was excised and distended for 30 minutes using a solution containing either Adv(5)-CMV (control group) or Adv(5)-CMV/Pro-UK (treatment group). Next, the jugular vein was reversed and interposed into the divided carotid artery of the same rat. On the 14th day after transfection, vein grafts of the control group were collected in order to perform a fibrinolysis test for prourokinase (Pro-UK) activity. On the 2nd, 7th, 14th, 28th, and 60th day, the vein grafts of the treatment group were likewise collected in order to detect prourokinase activity. On the 28th day, the vein grafts of both groups were explanted to evaluate the (3)H-TDR incorporation so that pathologic analysis could be performed.
RESULTSPro-UK activity could not be detected in the control group, while in the treatment group, the Pro-UK activity could be detected from the 2nd day onwards, peaking on the 7th day and declining from the 14th day, but yet persisting at a low level for a further month. The amount of (3)H-TDR incorporated in the control group was higher than that in the treatment group. Pathologic analysis demonstrated that vein grafts of both groups exhibited wall thickening, but that the degree of graft neointimal hyperplasia and reduction of the graft lumen was greater in the control group than that in the treatment group. The occlusion rate of grafts in the control group was 20%. All grafts in the treatment group were patent.
CONCLUSIONSPro-UK gene transfer before vein grafting in vitro results in a high level of gene expression in the vein graft from the 7th day to 14th day. And its gene expression in the vein graft could reduce neointimal hyperplasia in the vein graft.
Animals ; Gene Expression ; Gene Transfer Techniques ; Hyperplasia ; Jugular Veins ; transplantation ; Male ; Rats ; Rats, Wistar ; Recombinant Proteins ; genetics ; Tunica Intima ; pathology ; Urokinase-Type Plasminogen Activator ; genetics ; Veins ; pathology ; transplantation
5.The curative effect of interventional embolization of middle meningeal artery for chronic subdural hematoma
Fei DING ; Zhenbao LI ; Zihuan ZHANG ; Xintong ZHAO ; Jiaqiang LIU ; Feiyun QIN ; Liying HU ; Gang ZHOU
Journal of Interventional Radiology 2024;33(1):12-16
Objective To evaluate the safety and efficacy of interventional embolization of middle meningeal artery(MMA)for the treatment of chronic subdural hematoma(CSDH).Methods The clinical data of 14 patients with CSDH(17 lesions in total),who were treated with simple embolization of MMA at the Yijishan Hospital of Wannan Medical College of China between July 2021 and July 2022,were retrospective analyzed.After superselective catheterization of MMA using a microcatheter was accomplished,Onyx-18 glue,a liquid embolization agent,was used to embolize the main trunk and the branches of MMA.Imaging follow-up was adopted at 30 days and 90 days after discharge from hospital to evaluate the absorption of hematoma,and the improvement of clinical symptoms was defined as the modified Rankin Scale score(mRS)being decreased≥1 point from the baseline value.Results Successful embolization of MMA was accomplished for all the 17 lesions in the 14 patients,and no procedure-related complications occurred.During the follow-up period,the clinical symptoms and signs were remarkably improved in all patients.The postoperative 90-day hematoma volume was reduced by more than 90%in 11 patients and by more than 40%in one patient,and in 2 patients the postoperative 30-day hematoma volume was reduced by more than 30%.Complete absorption of hematoma was seen in 11 patients,and partial absorption of hematoma was observed in 3 patients.Conclusion For the treatment of newly-developed or recurrent CSDH,interventional embolization of MMA is clinically safe and effective.(J Intervent Radiol,2024,32:12-16)
6.Visual analysis of the treatment of non-alcoholic fatty liver disease based on Web of Science
Baoqiang ZHU ; Mingming ZHANG ; Shiyu YANG ; Jiaqiang HU ; Wenyuan LI ; Enwu LONG
China Pharmacy 2023;34(18):2243-2249
OBJECTIVE To analyze the current status, hotspots and development trends of research on the treatment of non-alcoholic fatty liver disease (NAFLD), providing reference for subsequent research. METHODS Searching the Web of Science database, the literature related to the treatment of NAFLD from the establishment of the database to December 31, 2022 were collected. CiteSpace 6.1.R6 was used to construct a visual atlas, perform collaborative network analysis on authors, countries and institutions, and conduct keyword co-occurrence, clustering and emergence analysis to explore its research status and hotspots. RESULTS A total of 3 882 articles were included, and the number of publications had been increasing year by year. The top three countries in terms of publication volume were China, the United States, and Japan. The author with the highest volume of publications was Sanyal from the United States (37 articles), while the institution with the highest volume of publications was the University of California, San Diego (75 articles). A closely connected research team abroad mainly conducted large-scale randomized controlled trials (RCT) to evaluate the effectiveness and safety of various interventions, including medication and lifestyle, in treating NAFLD. However, domestic researches mainly focused on basic researches about the treatment of NAFLD with effective medicinal ingredients, and were characterized by traditional Chinese medicine. There were relatively few high-quality large-scale RCT studies related to it. Keyword analysis showed that researches in various countries mainly focused on regulating liver oxidative stress and inflammation, improving the overall balance of glucose and lipid metabolism. Except for hypoglycemic drugs, drugs that act on various comprehensive metabolic homeostasis targets in the body had entered clinical research, and had enormous therapeutic potential. CONCLUSIONS The research on NAFLD treatment continues to grow in popularity and tends to research targets and drugs for regulating systemic metabolic homeostasis. As the main force of research, China should strengthen communication with the international community, grasp the trends and directions of basic research, attach importance to clinical research, and continuously tap the therapeutic potential of traditional Chinese medicine.